Infective Endocarditis After Transcatheter Pulmonary Valve Replacement Using the Melody Valve
Author(s) -
Doff B. McElhinney,
Lee Benson,
Andreas Eicken,
Jacqueline Kreutzer,
Robert F. Padera,
Evan M. Zahn
Publication year - 2013
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.112.000087
Subject(s) - medicine , infective endocarditis , endocarditis , valve replacement , surgery , implant , ventricular outflow tract , prospective cohort study , incidence (geometry) , pulmonary valve , percutaneous , clinical trial , stenosis , physics , optics
Transcatheter (percutaneous) pulmonary valve (TPV) replacement has emerged as a viable therapy for right ventricular outflow tract conduit dysfunction. Little is known about the incidence, clinical course, and outcome of infective endocarditis (IE) after TPV implant. We reviewed combined data from 3 ongoing prospective multicenter trials to evaluate the experience with IE among patients undergoing TPV replacement using the Melody valve.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom